Government Announces Meeting About Meeting With No Details
Published Date: 12/15/2025
Notice
Summary
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a virtual meeting on January 28, 2026, to discuss important updates and review grant applications. This affects researchers and organizations seeking funding for diabetes, digestive, and kidney disease studies. The meeting includes a public session and a closed session to protect private info, with no registration needed to join online.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Virtual Public Meeting — No Registration
There will be a virtual open meeting of the National Diabetes and Digestive and Kidney Diseases Advisory Council on January 28, 2026, from 1:00 p.m. to 1:45 p.m. EST. You do not need to register to join the public online session, and the agenda will be posted on the Institute's webpage.
Closed Session to Review Grant Applications
On January 28, 2026, from 2:00 p.m. to 3:00 p.m. EST the Council will hold a closed virtual session to review and evaluate grant applications. The closed session is being held to protect confidential trade secrets, commercial property, and personal information as allowed by 5 U.S.C. 552b(c)(4) and (c)(6).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-22795, Center for Scientific Review; Cancellation of Meeting
The Center for Scientific Review has canceled its December 18, 2025 meeting about using digital tools to study Alzheimer's and related dementias. This change affects researchers and staff who planned to attend, but no costs or new dates were mentioned. Everyone can relax for now as the meeting won’t happen as scheduled.
Next: 2025-22797, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings in February 2026 to review important health research grant applications. These meetings protect private info and trade secrets while deciding who gets funding. Researchers applying for fellowships and HIV-related studies should note these dates as they impact grant decisions and funding timelines.